Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 93,302 shares at $12.30 ($1.1M) on 2024-08-23, disclosed to the SEC on 2024-08-23.
Scheduled sale ($1.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.30 | 46,651 | $574K | 50.0% |
| 2 | $12.30 | 46,651 | $574K | 50.0% |
| Total | $12.30 avg | 93,302 | $1.1M | 100% |
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |